Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances

At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangan, Patricia, Stadtmauer, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857331/
https://www.ncbi.nlm.nih.gov/pubmed/33598318
http://dx.doi.org/10.6004/jadpro.2020.11.3.5
_version_ 1783646427361050624
author Mangan, Patricia
Stadtmauer, Edward
author_facet Mangan, Patricia
Stadtmauer, Edward
author_sort Mangan, Patricia
collection PubMed
description At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy.
format Online
Article
Text
id pubmed-7857331
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573312021-02-16 Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances Mangan, Patricia Stadtmauer, Edward J Adv Pract Oncol Meeting Reports At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857331/ /pubmed/33598318 http://dx.doi.org/10.6004/jadpro.2020.11.3.5 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Mangan, Patricia
Stadtmauer, Edward
Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
title Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
title_full Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
title_fullStr Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
title_full_unstemmed Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
title_short Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
title_sort adoptive cell therapies: keeping pace with new and emerging advances
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857331/
https://www.ncbi.nlm.nih.gov/pubmed/33598318
http://dx.doi.org/10.6004/jadpro.2020.11.3.5
work_keys_str_mv AT manganpatricia adoptivecelltherapieskeepingpacewithnewandemergingadvances
AT stadtmaueredward adoptivecelltherapieskeepingpacewithnewandemergingadvances

Ejemplares similares